Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

Morgan Stanley, Upward Adjustment to Xiaomi EV’s Target Price

globalautonews Views  

Morgan Stanley, a U.S. investment bank, has announced an upward adjustment to the target price of Xiaomi, citing optimistic electric vehicle sales. While they believe in Xiaomi’s potential power, they further commented that Xiaomi needs to offer more to attract investors.

Xiaomi officially launched the SU7 model on March 28, and in just one day, they reportedly received 88,898 orders. The limited Founders Edition began shipping on April 3, and Lei Jun, Xiaomi’s CEO, announced that they have received over 100k confirmed orders and 40k fixed orders.

Morgan Stanley believes this popularity portrays that end-users are satisfied with Xiaomi’s vehicle design and the ‘Smartphone+Electric Vehicle+AIoT’ concept.

Morgan Stanley argued that production, delivery, and service will be critical factors in the short term, and continued innovation in ADAS and Smart Cockpit features will drive long-term value.

Morgan Stanley estimated the inherent value of Xiaomi EV to be $13.8 billion and projected that the average selling price will reach $38,800 by 2024-2025. They also predicted that the likely probability of Xiaomi EV’s bull market occurrence could create an even higher value of $17.1 billion.

Morgan Stanley suggested a 25% upside potential by raising the target price for Xiaomi’s Hong Kong-listed stocks from $2.23 to $2.55.

Morgan Stanley stated, “The excellent specifications and price of the SU7 model could be an attractive alternative for young couples/families looking for a medium to large sedan. Therefore, it could deliver pressure on both the entry-level models of luxury brands and the C-segment sedans of mass-market brands.”

globalautonews
content@viewusglobal.com

Comments0

300

Comments0

[BUSINESS] Latest Stories

  • Honda's NSX Returns: A 1,000-Horsepower Electric Rival to Lexus LFR
  • Honda’s S7 Electric SUV: A Major Player in the Race for EV Dominance
  • Lamborghini's First EV: A 2,000-Horsepower Beast Built for Speed and Emotion
  • Ford Revives Classic Design with the 2025 Bronco Heritage Edition
  • ID.EVERY1: Volkswagen's $21K Electric Vehicle Aims to Make Green Driving Accessible
  • Toyota’s bZ3X SUV Surges with 10,000 Pre-Orders: A New Era in EVs

You May Also Like

  • 1
    How Vitamin D Could Help Lower Colon Cancer Risk

    LIFESTYLE 

  • 2
    Yes, IVF Can Cause Weight Gain — Here's Why You Shouldn't Panic

    LIFESTYLE 

  • 3
    Red Jewels for Your Health: 7 Amazing Benefits of Pomegranates

    LIFESTYLE 

  • 4
    Hidden Danger: 5 'Healthy Foods' That Can Worsen Gout

    LIFESTYLE 

  • 5
    Spring’s Secret Weapon for Dry Coughs: Meet Liriope Tea

    LIFESTYLE 

Popular Now

  • 1
    FDA Approves $3.1M Gene Therapy for Rare, Painful Skin Disorder

    LIFESTYLE&nbsp

  • 2
    Experts Warn: Toss Your Expired Sunscreen Before It Hurts Your Skin

    LIFESTYLE&nbsp

  • 3
    New Drug Helps Patients with Myasthenia Gravis Breathe and Speak Easier

    LIFESTYLE&nbsp

  • 4
    Bristol-Myers’ Schizophrenia Drug Falls Short in Key Trial

    LIFESTYLE&nbsp

  • 5
    Novavax COVID Vaccine Still on Hold—More Trials Needed, Says FDA

    LIFESTYLE&nbsp

Must-Reads

  • 1
    How Vitamin D Could Help Lower Colon Cancer Risk

    LIFESTYLE 

  • 2
    Yes, IVF Can Cause Weight Gain — Here's Why You Shouldn't Panic

    LIFESTYLE 

  • 3
    Red Jewels for Your Health: 7 Amazing Benefits of Pomegranates

    LIFESTYLE 

  • 4
    Hidden Danger: 5 'Healthy Foods' That Can Worsen Gout

    LIFESTYLE 

  • 5
    Spring’s Secret Weapon for Dry Coughs: Meet Liriope Tea

    LIFESTYLE 

Popular Now

  • 1
    FDA Approves $3.1M Gene Therapy for Rare, Painful Skin Disorder

    LIFESTYLE 

  • 2
    Experts Warn: Toss Your Expired Sunscreen Before It Hurts Your Skin

    LIFESTYLE 

  • 3
    New Drug Helps Patients with Myasthenia Gravis Breathe and Speak Easier

    LIFESTYLE 

  • 4
    Bristol-Myers’ Schizophrenia Drug Falls Short in Key Trial

    LIFESTYLE 

  • 5
    Novavax COVID Vaccine Still on Hold—More Trials Needed, Says FDA

    LIFESTYLE